lobbying_activities: 2911166

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2911166	e528d1ef-e0d0-41c5-b93a-42d2ab2e2696	Q4	MARSHALL & POPP, LLC	401105121	BUTTERFLY NETWORK, INC.	2022	fourth_quarter	SCI	Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act, and H.R.2617, Consolidated Appropriations Act, 2023. Issues related to FDA regulation of medical devices, including including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R.6833, Making continuing appropriations for fiscal year 2023, and H.R.2617, Consolidated Appropriations Act, 2023.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2023-01-14T15:16:59-05:00